Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries

The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV - a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.